Combined neuroendocrine differentiation and androgen receptor hyperactivity in MAP37 and CHD1 null prostate cancer

被引：0
|
作者：
Rider, Leah C.
Rodrigues, Lindsey U.
Karimpour-Fard, Anis
Romero, Lina
Gillette, Claire
Costello, James C.
Cramer, Scott D.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1580
引用
收藏
页数：2
相关论文
共 42 条
  • [1] Determining gene expression regulated by androgen receptor variant 7 in co-loss of MAP3K7/CHD1 prostate cancer
    Gillette, Claire
    Jillson, Lauren
    Cramer, Scott
    CANCER RESEARCH, 2023, 83 (11)
  • [2] Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
    Su, Ruopeng
    Chen, Lei
    Jiang, Zhou
    Yu, Minghao
    Zhang, Weiwei
    Ma, Zehua
    Ji, Yiyi
    Shen, Kai
    Xin, Zhixiang
    Qi, Jun
    Xue, Wei
    Wang, Qi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer
    Rodrigues, Lindsey Ulkus
    Rider, Leah
    Nieto, Cera
    Romero, Lina
    Karimpour-Fard, Anis
    Loda, Massimo
    Lucia, M. Scott
    Wu, Min
    Shi, Lihong
    Cimic, Adela
    Sirintrapun, S. Joseph
    Nolley, Rosalie
    Pac, Colton
    Chen, Haitao
    Peehl, Donna M.
    Xu, Jianfeng
    Liu, Wennuan
    Costello, James C.
    Cramer, Scott D.
    CANCER RESEARCH, 2015, 75 (06) : 1021 - 1034
  • [4] Coordinate loss of CHD1 and MAP3K7 promotes aggressive prostate cancer
    Ulkus, Lindsey
    Rider, Leah
    Nieto, Cera
    Romero, Lina
    Chen, Haitao
    Loda, Massimo
    Liu, Wennuan
    Xu, Jianfeng
    Cramer, Scott
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer
    Segawa, N
    Mori, I
    Utsunomiya, H
    Nakamura, M
    Nakamura, Y
    Shan, L
    Kakudo, K
    Katsuoka, Y
    PATHOLOGY INTERNATIONAL, 2001, 51 (06) : 452 - 459
  • [6] HYPOXIA INDUCE NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER VIA ANDROGEN RECEPTOR RELATED SIGNALS
    Cui, Yun
    Sun, Yin
    Yang, Yang
    Hu, Shuai
    Niu, Yinong
    Zhang, Xiaodong
    Yeh, Shuyuan
    Chang, Chawnshang
    Jin, Jie
    JOURNAL OF UROLOGY, 2020, 203 : E1205 - E1206
  • [7] Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status
    Bonkhoff, H
    ANNALS OF ONCOLOGY, 2001, 12 : S141 - S144
  • [8] MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1
    Jillson, Lauren K.
    Rider, Leah C.
    Rodrigues, Lindsey U.
    Romero, Lina
    Karimpour-Fard, Anis
    Nieto, Cera
    Gillette, Claire
    Torkko, Kathleen
    Danis, Etienne
    Smith, Elizabeth E.
    Nolley, Rosalie
    Peehl, Donna M.
    Lucia, M. Scott
    Costello, James C.
    Cramer, Scott D.
    MOLECULAR CANCER RESEARCH, 2021, 19 (07) : 1123 - 1136
  • [9] MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells
    Bayne, Robert S.
    Puckett, Shelby
    Rodrigues, Lindsey Ulkus
    Cramer, Scott D.
    Lee, Jingyun
    Furdui, Cristina M.
    Chou, Jeff W.
    Miller, Lance D.
    Ornelles, David A.
    Lyles, Douglas S.
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 : 496 - 507
  • [10] Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor
    Turpin, Anthony
    Delliaux, Carine
    Parent, Pauline
    Chevalier, Hortense
    Escudero-Iriarte, Carmen
    Bonardi, Franck
    Vanpouille, Nathalie
    Flourens, Anne
    Querol, Jessica
    Carnot, Aurelien
    Leroy, Xavier
    Herranz, Nicolas
    Lanel, Tristan
    Villers, Arnauld
    Olivier, Jonathan
    Touzet, Helene
    de Launoit, Yvan
    Tian, Tian V.
    Duterque-Coquillaud, Martine
    BRITISH JOURNAL OF CANCER, 2023, 129 (12) : 1903 - 1914
12345